Ferola Peter 4

Accession 0001574774-19-000057

CIK 0001574774other

View on SEC.gov Company Profile

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 4:18 PM ET

Size

23.4 KB

Accession

0001574774-19-000057

Insider Transaction Report

Form 4

Period: 2019-09-04

BIOTELEMETRY, INC.BEAT

Ferola Peter

Senior Vice President

Transactions

Exercise/Conversion
Stock Options (Right to Buy)
2019-09-04−10,293→ 3,433 total
Exercise: $9.57Exp: 2026-02-15→ Common Stock (10,293 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2019-09-04−1,853→ 5,561 total
Exercise: $33.35Exp: 2028-02-14→ Common Stock (1,853 underlying)
Sale
Common Stock
2019-09-04$39.03/sh−44,276$1,728,092→ 8,507 total
Exercise/Conversion
Common Stock
2019-09-04$9.57/sh+10,293$98,504→ 47,666 total
Exercise/Conversion
Common Stock
2019-09-04$33.35/sh+1,853$61,798→ 52,783 total
Exercise/Conversion
Common Stock
2019-09-04$8.68/sh+6,835$59,328→ 19,622 total
Exercise/Conversion
Common Stock
2019-09-04$10.36/sh+17,751$183,900→ 37,373 total
Exercise/Conversion
Common Stock
2019-09-04$24.65/sh+3,264$80,458→ 50,930 total
Exercise/Conversion
Stock Options (Right to Buy)
2019-09-04−17,751→ 0 total
Exercise: $10.36Exp: 2025-02-16→ Common Stock (17,751 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2019-09-04−6,835→ 0 total
Exercise: $8.68Exp: 2024-02-14→ Common Stock (6,835 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2019-09-04−3,264→ 3,265 total
Exercise: $24.65Exp: 2027-02-14→ Common Stock (3,264 underlying)

Footnotes (7)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2019.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $38.48 to $39.94, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
[F3]The stock options vested in four equal annual installments and were fully exercisable as of December 31, 2017.
[F4]The stock options vested in four equal annual installments and were fully exercisable as of December 31, 2018.
[F5]The stock options vested at the rate of 25% on each of December 31, 2016, 2017 and 2018 with the remainder of the stock options vesting on December 31, 2019; provided that the option holder remains in continuous service through the applicable vesting date.
[F6]The stock options vested at the rate of 25% on each of December 31, 2017 and 2018 with the remainder of the stock options vesting in equal amounts on each of December 31, 2019 and 2020; provided that the option holder remains in continuous service through the applicable vesting date.
[F7]The stock options vested at the rate of 25% on the first anniversary of the grant date with the remainder of the stock options vesting in equal amounts on the second, third and fourth anniversaries of the grant date; provided that the option holder remains in continuous service through the applicable vesting date.

Documents

1 file

4
wf-form4_156780108219472.xmlPrimary
FORM 4

Issuer

BIOTELEMETRY, INC.

CIK 0001574774

→

Entity typeother

Related Parties

filerCIK 0001465497

Filing Metadata

Form type: 4
Filed: Sep 5, 8:00 PM ET
Accepted: Sep 6, 4:18 PM ET
Size: 23.4 KB

View on SEC.gov